Iaso AMS Overview
- Year Founded
-
2023
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
1
Iaso AMS General Information
Description
Developer of an analytics platform designed for medical professionals to detect Acute Respiratory Distress Syndrome. The company's platform detects the early onset of Acute Respiratory Distress Syndrome and helps in prior intervention to reduce disease progression, enabling medical professionals to make swift, evidence-based decisions and achieve suitable outcomes for critically ill patients.
Contact Information
Website
www.iasoams.comCorporate Office
- St Johns Road
- St Johns
- Auckland, 1027
- New Zealand
Corporate Office
- St Johns Road
- St Johns
- Auckland, 1027
- New Zealand
Iaso AMS Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 01-Dec-2023 | Completed | Generating Revenue |
Iaso AMS Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| WNT Ventures | Venture Capital | Minority |
Iaso AMS FAQs
-
When was Iaso AMS founded?
Iaso AMS was founded in 2023.
-
Where is Iaso AMS headquartered?
Iaso AMS is headquartered in Auckland, New Zealand.
-
What industry is Iaso AMS in?
Iaso AMS’s primary industry is Decision/Risk Analysis.
-
Is Iaso AMS a private or public company?
Iaso AMS is a Private company.
-
What is Iaso AMS’s current revenue?
The current revenue for Iaso AMS is .
-
Who are Iaso AMS’s investors?
WNT Ventures has invested in Iaso AMS.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process